The Broker Innovation Lab celebrates brokers and other benefits stakeholders who have embraced the changing marketplace to position themselves and their business for future success
Sens. Tim Kaine and Mark R. Warner, who both have championed to lower the cost of prescription drugs, applauded Sanofi, Novo Nordisk and Eli Lilly – the three major insulin manufacturers – for slashing prices, effective Jan. 1, 2024.
Despite the Biden administration's numerous initiatives to crack down on the high cost of drugs, several big drugmakers will hike prices this month, with Pfizer announcing over a quarter of the increases.
By adopting an open, more flexible attitude, employers can ensure that hormonal health is prioritized in the workplace, and that hormonal-related issues are managed mindfully.
Joining Walgreens, CVS Health and Walmart, Amazon is the latest retail pharmacy to experiment with drone delivery of prescriptions, promising dropoff in 60 minutes or less to "narrow the golden window from diagnosis to treatment."
While Congress moves closer to pharmacy benefit manager reform with new legislation pending, "achieving large reductions in prescription drug costs" will require a different approach, says the Brookings Institution.
Blood clot drugs Eliquis and Jardiance made the list, released on Tuesday, amid lawsuits filed by their manufacturers, attempting to block the government's effort to control drug prices.
The Biden administration released draft guidance on a new program that allows Medicare prescription drug plan enrollees to pay out-of-pocket drug costs in monthly installments beginning in 2025.
However, it's likely the upcoming Medicare drug price negotiations will have some spillover effect, as the prices are likely to become a new ceiling for other insurers as well, suggests a new AARP report.
Following Biden's $35 cap on insulin costs for seniors on Medicare and three pharma companies agreeing to the cost reduction, Amazon is now giving its online customers instant discounts for the diabetes drug.